江苏汉邦科技股份有限公司 2025 年第二次临时股东会会议资料 证券代码：688755 证券简称：汉邦科技 江苏汉邦科技股份有限公司 2025 年第二次临时股东会会议资料 二〇二五年九月 | | | 江苏汉邦科技股份有限公司 2025 年第二次临时股东会会议资料 六、会议召开期间，股东准备在股东会发言的，应当事先在签到处登记，发 言前应当举手示意，经会议主持人许可方可发言。股东及代理人提问应围绕本次 会议议题，简明扼要，时间不超过 5 分钟。股东不得打断会议报告人的报告或其 他股东及股东代理人的发言,在股东会进行表决时，股东及股东代理人不再进行 发言。违反前述规定的，会议主持人可以拒绝或制止。 1 江苏汉邦科技股份有限公司 2025 年第二次临时股东会会议须知 为了维护全体股东的合法权益，确保公司股东会的正常秩序和议事效率，根 据《中华人民共和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》 (以下简称《证券法》)、《上市公司股东会规则》以及《江苏汉邦科技股份有限 公司章程》(以下简称《公司章程》)等相关规定，特制订 2025 年第二次临时股 东会须知。 一、为保证本次会议的严肃性和正常秩序，切实维 ...

证券之星消息，8月27日医疗器械板块较上一交易日下跌1.98%，汉邦科技领跌。当日上证指数报收于 3800.35，下跌1.76%。深证成指报收于12295.07，下跌1.43%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002950 | 奥美医疗 | 10.74 | 10.04% | 43.66万 | | 4.67亿 | | 603222 | 济民健康 | 10.04 | 9.97% | 116.57万 | | 11.18亿 | | 301363 | 美好医疗 | 25.58 | 4.45% | 46.30万 | | 12.20亿 | | 300832 | 新产业 | 59.65 | 3.38% | 9.77万 | | 5.87亿 | | 688301 | 奕瑞科技 | 114.54 | 3.19% | 4.91万 | | 5.68亿 | | 688607 | 康众医疗 | 30.10 | 2.73% | 7.30万 | | 2.21亿 | | ...

Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. reported a revenue of 349 million yuan and a net profit of 27.8 million yuan for the first half of 2025, alongside a cash dividend plan of 8.8 million yuan to shareholders [2] Group 1: Financial Performance - The company achieved a revenue of 349 million yuan and a net profit of 27.8 million yuan during the reporting period [2] - The small molecule business generated a revenue of 248 million yuan, reflecting a year-on-year growth of 17.44% [2] - The compound annual growth rate (CAGR) of the company's revenue from 2022 to 2024 is 19.75% [2] Group 2: R&D and Technological Advancements - The company has overcome challenges in chromatography linear scaling technology, enabling product scaling from grams to kilograms [3] - R&D expenses for the first half of the year amounted to 20.99 million yuan, with a CAGR of 20.14% in R&D investment over the past three years [3] - Ongoing projects include the development of high-efficiency peptide synthesis and purification equipment, utilizing advanced industry technologies [3] Group 3: Market Outlook and Strategic Focus - The global chromatography equipment market is expanding, particularly in China, driven by the rapid development of downstream industries [3] - The company plans to continue focusing on its core chromatography product business, enhancing product performance based on market demand [3] - The goal is to become a leading enterprise in the R&D, production, and industrialization of chromatography separation and purification equipment in China [3]

Group 1 - Aofei Data achieved a net profit of 87.89 million yuan in the first half of 2025, a year-on-year increase of 16.09% [1] - Aofei Data's revenue for the same period was 1.148 billion yuan, up 8.20% year-on-year [1] - The company specializes in IDC services, internet business, system integration, and distributed photovoltaic energy-saving services [1] Group 2 - Meilan De reported a net profit of 63.92 million yuan, a year-on-year decrease of 11.96% [1] - The company's revenue was 241 million yuan, reflecting a growth of 5.62% year-on-year [1] - Meilan De focuses on the research, production, sales, and service of medical devices related to pelvic and obstetric rehabilitation [1] Group 3 - Jiuan Medical posted a net profit of 920 million yuan, a significant year-on-year increase of 52.91% [1] - The company's revenue decreased by 43.35% to 765 million yuan [1] - Jiuan Medical specializes in the research, production, and sales of home medical devices [2] Group 4 - Hanbang Technology's net profit fell by 26.24% to 27.80 million yuan [2] - The company achieved a revenue of 349 million yuan, a growth of 5.99% year-on-year [2] - Hanbang Technology provides professional separation and purification equipment, consumables, and technical solutions for the pharmaceutical and life sciences sectors [2] Group 5 - Jinjing Environment reported a net profit of 78.69 million yuan, a year-on-year increase of 13.73% [2] - The company's revenue was 782 million yuan, reflecting a growth of 1.70% [2] - Jinjing Environment focuses on investment operation management services and equipment manufacturing in the environmental sanitation sector [2] Group 6 - Tianbao Infrastructure achieved a net profit of 118 million yuan, a remarkable year-on-year increase of 2106.58% [3] - The company's revenue decreased by 8.31% to 486 million yuan [3] - Tianbao Infrastructure is involved in real estate development, property leasing, and management [4] Group 7 - Weihuaxin Materials reported a net profit of 83.15 million yuan, a year-on-year decrease of 52.91% [5] - The company's revenue was 437 million yuan, down 30.71% year-on-year [5] - Weihuaxin Materials specializes in the research and production of chlorotoluene and trifluoromethylbenzene products [5] Group 8 - Tianchen Medical posted a net profit of 48.21 million yuan, a year-on-year increase of 67.10% [6] - The company's revenue was 156 million yuan, reflecting a growth of 17.66% [6] - Tianchen Medical focuses on the research, innovation, and production of high-end surgical staplers [6] Group 9 - Greenland Holdings reported a net loss of 3.506 billion yuan in the first half of 2025 [8] - The company's revenue was 9.45 billion yuan, down 18.06% year-on-year [8] - Greenland Holdings is involved in various financial services including securities, futures, and trust [8] Group 10 - Wukuang Capital's net profit decreased by 41.47% to 525 million yuan [9] - The company achieved a total revenue of 623 million yuan, a significant increase of 144.86% [9] - Wukuang Capital operates in the financial sector, providing services such as securities and leasing [9] Group 11 - Yutong Technology reported a net profit of 554 million yuan, a year-on-year increase of 11.42% [10] - The company's revenue was 7.876 billion yuan, reflecting a growth of 7.10% [10] - Yutong Technology specializes in the research, design, production, and sales of paper packaging products [10] Group 12 - Wewei Co. posted a net profit of 120 million yuan, a year-on-year decrease of 20.14% [11] - The company's revenue was 1.521 billion yuan, down 12.76% year-on-year [11] - Wewei Co. focuses on the production and sales of various food and beverage products [11] Group 13 - Tongfang Co. reported a net loss of 256 million yuan in the first half of 2025 [12] - The company's revenue was 5.667 billion yuan, down 10.09% year-on-year [12] - Tongfang Co. is engaged in the development of smart technology and nuclear technology applications [12] Group 14 - Liugang Co. achieved a net profit of 368 million yuan, a year-on-year increase of 579.54% [13] - The company's revenue was 34.675 billion yuan, down 8.32% [13] - Liugang Co. specializes in coke, sintering, iron, steel smelting, and steel processing [13] Group 15 - China National Petroleum Corporation reported a net profit of 83.993 billion yuan, with a proposed dividend of 0.22 yuan per share [14] - The company's revenue was 1.45 trillion yuan, down 6.7% year-on-year [14] - The company is involved in oil and gas exploration, production, refining, and sales [14] Group 16 - Fangda Carbon's net profit decreased by 68.31% to 54.53 million yuan [15] - The company's revenue was 1.690 billion yuan, down 28.13% year-on-year [15] - Fangda Carbon specializes in the research, production, and sales of graphite and carbon materials [15] Group 17 - Xinmai Medical reported a net profit of 31.5 million yuan, a year-on-year decrease of 22.03% [18] - The company's revenue was 714 million yuan, down 9.24% year-on-year [18] - Xinmai Medical focuses on the research, production, and sales of vascular intervention medical devices [18] Group 18 - Hengbao Co. posted a net profit of 35.35 million yuan, a year-on-year decrease of 44.41% [19] - The company's revenue was 430 million yuan, down 8.64% year-on-year [19] - Hengbao Co. specializes in high-end intelligent products and digital security solutions [19] Group 19 - Zhongji Xuchuang reported a net profit of 3.995 billion yuan, a year-on-year increase of 69.40% [20] - The company's revenue was 14.789 billion yuan, reflecting a growth of 36.95% [20] - Zhongji Xuchuang specializes in high-end optical communication modules and devices [20] Group 20 - Guangxian Media achieved a net profit of 2.229 billion yuan, a year-on-year increase of 371.55% [21] - The company's revenue was 3.242 billion yuan, up 143.00% year-on-year [21] - Guangxian Media focuses on investment, production, and distribution of film projects [21] Group 21 - Huarun Pharmaceutical reported a net profit of 37.33 million yuan, a year-on-year decrease of 49.01% [23] - The company's revenue was 624 million yuan, down 19.13% year-on-year [23] - Huarun Pharmaceutical specializes in pharmaceuticals, medical devices, and health products [23] Group 22 - Huawai Technology posted a net profit of 12.7 million yuan, a year-on-year increase of 56.18% [24] - The company's revenue was 937 million yuan, reflecting a growth of 32.62% [24] - Huawai Technology focuses on the research, production, and sales of high-end elastic components [24]

Group 1 - The core viewpoint of the news is that Hanbang Technology experienced a stock price increase of 1.63% on August 26, with a trading volume of 135 million yuan [1] - On the same day, Hanbang Technology had a financing purchase amount of 21.54 million yuan and a net financing purchase of 10.17 million yuan, with a total financing and securities balance of 86.38 million yuan [1] - The financing balance of Hanbang Technology accounts for 9.64% of its circulating market value [1] Group 2 - As of June 30, 2025, Hanbang Technology's revenue for the first half of the year was 349 million yuan, representing a year-on-year growth of 5.99% [1] - The net profit attributable to the parent company for the same period was 27.80 million yuan, showing a year-on-year decrease of 26.24% [1] - The number of shareholders decreased by 48.43% to 9,372, while the average circulating shares per person increased by 93.92% to 1,764 shares [1] Group 3 - The largest circulating shareholder of Hanbang Technology as of June 30, 2025, is Dongfanghong Medical Upgrade Stock Initiation A, holding 483,700 shares as a new shareholder [2]

格隆汇8月26日丨汉邦科技(688755.SH)发布中报，2025上半年实现营业总收入3.49亿元，同比增长 5.99%；归属母公司股东净利润2779.76万元，同比下降26.24%；基本每股收益为0.4元。此外，拟对全 体股东每10股派发现金红利1元(含税)。 ...

证券代码：688755 证券简称：汉邦科技 公告编号：2025-022 江苏汉邦科技股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 2025年第二次临时股东会 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 9 月 11 日 14 点 30 分 召开地点：江苏省淮安市淮安经济技术开发区集贤路 1-9 号公司三楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 9 月 11 日 至2025 年 9 月 11 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 股东会召开日期：2025年9月11日 本次股东会采用的网 ...

Core Insights - The company, Hanbang Technology, reported a revenue of 349 million yuan for the first half of 2025, representing a year-on-year growth of 5.99% and a net profit of 27.8 million yuan [1] - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares, totaling 8.8 million yuan, which accounts for 31.66% of the net profit attributable to shareholders [1] - Hanbang Technology continues to implement a technology-leading strategy, enhancing its technical capabilities and exploring new technologies and fields [1] Financial Performance - Revenue for the first half of 2025 reached 349 million yuan, with a net profit of 27.8 million yuan [1] - The company experienced a 20% increase in new orders compared to the same period last year, driven by rising customer demand [1] Industry Position - Hanbang Technology specializes in chromatography technology, providing separation and purification equipment, consumables, and technical solutions primarily for the pharmaceutical and life sciences sectors [1] - The company has developed a comprehensive product matrix for large and small molecule drug separation and purification equipment, serving over 2,000 customers domestically and internationally [3] Technological Advancements - The company has made significant breakthroughs in chromatography linear scaling technology, enabling the transition of products from gram to kilogram scale [2] - Hanbang Technology's innovations have disrupted foreign monopolies in related technologies and products, positioning it as a leading domestic enterprise in chromatography separation and purification equipment [2] Product Offerings - The company offers a range of products including large and small molecule drug separation and purification equipment, addressing the needs of industrial production and laboratory research [3] - Hanbang Technology has established core technologies in preparative chromatography, system integration, and intelligent chromatography control software [3]

证券代码：688755 证券简称：汉邦科技 公告编号：2025-017 江苏汉邦科技股份有限公司 第一届董事会第二十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 江苏汉邦科技股份有限公司（以下简称"汉邦科技"或"公司"）第一届董 事会第二十二次会议于 2025 年 8 月 25 日以现场和通讯相结合的方式在公司会议 室召开，会议通知于 2025 年 8 月 15 日通过通讯方式送达全体董事。本次会议由 董事长张大兵先生召集并主持，会议应出席董事 9 人，实际出席董事 9 人，公司 高级管理人员列席了会议。本次会议的召集、召开和表决程序符合《中华人民共 和国公司法》等法律、法规和《公司章程》的有关规定。 二、董事会会议审议情况 经与会董事审议，并对议案进行了投票表决，通过了以下决议： （一）审议通过了《关于公司董事会换届选举暨提名第二届董事会非独立 董事候选人的议案》 关于该事项的具体内容，详见公司同日刊登于上海证券交易所网站 （http://www.sse.com.cn）及公司指 ...

证券代码：688755 证券简称：汉邦科技 公告编号：2025-021 江苏汉邦科技股份有限公司 关于 2025 年半年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每 10 股分配比例：A 股每 10 股派发现金红利 1.00 元（含税），不进行 资本公积金转增股本，不送红股。 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体日 期将在权益分派实施公告中明确。 在实施权益分派的股权登记日前江苏汉邦科技股份有限公司（以下简称 "公司"）总股本发生变动的，拟维持分配总额不变，相应调整每股分配比例， 并将另行公告具体调整情况。 一、2025 年半年度利润分配预案内容 江苏汉邦科技股份有限公司 2025 半年度合并报表归属于上市公司股东的净 利润为 27,797,574.46 元，截至 2025 年 6 月 30 日，公司合并报表可供分配利润 为 171,915,960.89 元，母公司可供分配利润为 188,848,506.98 元（以上数据未 经审计）。经公司第一届董事会第 ...